Libtayo plus platinum-doublet chemotherapy led to a 29% reduction in risk of death compared to chemotherapy alone
Month: August 2021
Planned Phase II study to combine the BET inhibitor with momelotinib
UK Competition and Markets Authority provisionally finds drug companies broke competition law
A group of scientists in Warsaw found a way to better control the path of light to and […]
“You hear the noises, but they don’t bother you at all”: Since 2019, the “Pengunaut Trainer” has been […]
To host big sporting events such as the Olympic Games and the Fédération Internationale de Football Association (FIFA) […]
Updated Date: Thu, 29 Jul 2021 00:00:00 EDT
An NHS boss who wrongly assured the General Medical Council that a doctor he was reporting to the […]
Sanofi, Regeneron stop Libtayo-chemo lung cancer trial early on strong survival data fkansteiner Thu, 08/05/2021 – 11:36
Moderna, citing variants and waning immunity, expects COVID-19 boosters to become a fact of life esagonowsky Thu, 08/05/2021 […]